Children who are genetically susceptible to type 1 diabetes could see their risk of the condition reduced if they get enough vitamin D. This is the conclusion of a new study published in the journal Diabetes. Researchers found that children with low blood levels of vitamin D were more likely to experience islet autoimmunity, compared[…]
The first automated insulin delivery device for type 1 diabetes has been approved by the U.S. Food and Drug Administration for people aged 14 and older. Often called an “artificial pancreas,” the MiniMed 670G hybrid closed loop system automatically monitors blood sugar levels every five minutes and delivers insulin when needed with little or no[…]
Ridgefield, Conn., and Indianapolis, May 31, 2016 – The U.S. Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes (T2D) in adults. Jentadueto XR, which is marketed by Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY), is the seventh new treatment[…]